Global Wealth Management Investment Advisory’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $12.7M | Buy |
50,291
+3,270
| +7% | +$704K | 1.8% | 17 |
|
|
2026
Q1 | $10.2M | Buy |
47,021
+1,770
| +4% | +$393K | 1.6% | 17 |
|
|
2025
Q4 | $10.3M | Sell |
45,251
-304
| -0.7% | -$69.3K | 1.66% | 18 |
|
|
2025
Q3 | $10.5M | Buy |
45,555
+3,339
| +8% | +$680K | 1.77% | 16 |
|
|
2025
Q2 | $7.84M | Buy |
42,216
+5,884
| +16% | +$1.09M | 1.47% | 17 |
|
|
2025
Q1 | $7.61M | Buy |
36,332
+6,318
| +21% | +$1.23M | 1.52% | 18 |
|
|
2024
Q4 | $5.33M | Buy |
30,014
+5,839
| +24% | +$1.07M | 1.1% | 24 |
|
|
2024
Q3 | $4.77M | Buy |
24,175
+1,237
| +5% | +$231K | 1.03% | 29 |
|
|
2024
Q2 | $3.93M | Buy |
22,938
+1,430
| +7% | +$237K | 0.92% | 39 |
|
|
2024
Q1 | $3.92M | Buy |
21,508
+13,311
| +162% | +$2.29M | 0.96% | 35 |
|
|
2023
Q4 | $1.27M | Buy |
8,197
+364
| +5% | +$53.1K | 0.33% | 83 |
|
|
2023
Q3 | $1.17M | Buy |
7,833
+392
| +5% | +$57.5K | 0.33% | 82 |
|
|
2023
Q2 | $1M | Sell |
7,441
-240
| -3% | -$35.2K | 0.28% | 88 |
|
|
2023
Q1 | $1.22M | Buy |
7,681
+513
| +7% | +$78.4K | 0.37% | 74 |
|
|
2022
Q4 | $1.16M | Buy |
7,168
+56
| +0.8% | +$8.59K | 0.38% | 72 |
|
|
2022
Q3 | $955K | Buy |
7,112
+615
| +9% | +$88.3K | 0.34% | 79 |
|
|
2022
Q2 | $995K | Sell |
6,497
-2,173
| -25% | -$332K | 0.34% | 73 |
|
|
2022
Q1 | $1.41M | Buy |
8,670
+330
| +4% | +$47.9K | 0.42% | 72 |
|
|
2021
Q4 | $1.13M | Buy |
8,340
+414
| +5% | +$48.9K | 0.34% | 75 |
|
|
2021
Q3 | $855K | Buy |
7,926
+1,130
| +17% | +$129K | 0.27% | 84 |
|
|
2021
Q2 | $766K | Buy |
6,796
+167
| +3% | +$18.8K | 0.25% | 84 |
|
|
2021
Q1 | $717K | Buy |
6,629
+799
| +14% | +$85.5K | 0.26% | 82 |
|
|
2020
Q4 | $625K | Buy |
5,830
+535
| +10% | +$51.4K | 0.24% | 83 |
|
|
2020
Q3 | $464K | Sell |
5,295
-155
| -3% | -$14.6K | 0.2% | 83 |
|
|
2020
Q2 | $535K | Buy |
5,450
+831
| +18% | +$73.2K | 0.23% | 83 |
|
|
2020
Q1 | $352K | Buy |
4,619
+8
| +0.2% | +$681 | 0.18% | 86 |
|
|
2019
Q4 | $408K | Sell |
4,611
-59
| -1% | -$4.9K | 0.17% | 86 |
|
|
2019
Q3 | $354K | Buy |
4,670
+393
| +9% | +$26.9K | 0.16% | 87 |
|
|
2019
Q2 | $311K | Sell |
4,277
-11,847
| -73% | -$931K | 0.15% | 88 |
|
|
2019
Q1 | $1.3M | Sell |
16,124
-2,594
| -14% | -$212K | 0.67% | 54 |
|
|
2018
Q4 | $1.73M | Buy |
+18,718
| New | +$1.65M | 1% | 35 |
|
Other funds holding ABBV
Global Wealth Management Investment Advisory's ABBV Position: Q2 2026 in Review
Global Wealth Management Investment Advisory increased its AbbVie (ABBV) stake by 7% in Q2 2026, buying an estimated $704K and bringing the position to 50,291 shares worth $12.7M. The position accounts for 1.8% of the portfolio, ranked #17.
Global Wealth Management Investment Advisory first reported a position in ABBV in Q4 2018 and has held it in 31 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Global Wealth Management Investment Advisory held 50,291 shares of AbbVie worth $12.7M as of Q2 2026.
- Global Wealth Management Investment Advisory bought 3,270 AbbVie shares in Q2 2026, an estimated $704K.
- AbbVie made up 1.8% of Global Wealth Management Investment Advisory's portfolio in Q2 2026, its #17 holding.
- Global Wealth Management Investment Advisory first reported a position in AbbVie in Q4 2018 and has held it in 31 quarters since.
- 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Global Wealth Management Investment Advisory's 13F filing for Q2 2026, filed 29 Jul 2026.